The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise
Launched by UNIVERSITY OF CENTRAL FLORIDA · May 14, 2025
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the menstrual cycle affects the body’s immune response and recovery after resistance exercise in healthy women. Researchers want to find out if different phases of the menstrual cycle—specifically the early follicular, late follicular, and mid-luteal phases—change how immune cells react and how muscle damage and recovery occur after working out. The goal is to improve our understanding of how women might recover from exercise at different times in their menstrual cycle.
To participate, women must be between 18 and 40 years old, weigh at least 110 pounds, and have been actively resistance training for at least six months. Participants will engage in resistance exercise during three different menstrual phases, provide blood samples to measure immune responses and muscle damage, and share information about their sleep, mood, and recovery through questionnaires. It’s important to note that women who are pregnant, using hormonal birth control, or have certain medical conditions may not be eligible for the study. This research could help tailor exercise and recovery strategies for women based on their menstrual cycle.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women between the ages of 18 and 40.
- • Must weigh at least 110 pounds.
- • Healthy as determined by medical history, physical activity readiness, and menstrual cycle questionnaires.
- • Actively resistance training for at least 6 months (minimum of 3 resistance training sessions per week, with at least one lower body session).
- • Pre-menopausal and have a regular menstrual cycle (eumenorrheic), with a clear start of menses (early follicular phase).
- • Not currently pregnant or planning to become pregnant during the study.
- • Have not used hormonal birth control or intrauterine devices in the past 3 months (or three full menstrual cycles).
- • Able to recall approximate start dates of their last 6 menstrual cycles.
- • Willing to follow study instructions, including avoiding exercise, alcohol, and caffeine before testing visits.
- • Free from previous or current lower body injuries that could limit performance.
- • Not regularly taking any medications that could interfere with the study.
- • Determined to have a high likelihood of successful blood draws by a certified phlebotomist.
- Exclusion Criteria:
- • Do not give consent to participate.
- • Have been determined unfit to participate based on medical or activity history (using health questionnaires).
- • Currently take prescription or over-the-counter medication that could affect the study results.
- • Have a chronic illness requiring medical care.
- • Not currently resistance-trained (don't meet the exercise requirement).
- • Pregnant or planning to become pregnant during the study.
- • Do not have regular periods or have been diagnosed as amenorrhoeic (absence of menstruation).
- • Currently taking any performance-enhancing drugs.
- • Currently using hormonal birth control or intrauterine devices (IUDs), or have used them in the past three months (or three full menstrual cycles).
- • Determined unlikely to have a successful blood draw by a trained phlebotomist.
- • Weigh less than 110 pounds.
About University Of Central Florida
The University of Central Florida (UCF) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to excellence in research and education, UCF leverages its diverse expertise and state-of-the-art facilities to conduct cutting-edge studies across various medical disciplines. The university's collaborative approach fosters partnerships with healthcare providers, industry leaders, and community organizations, ensuring that clinical trials are designed to address pressing health challenges while adhering to the highest ethical standards. UCF is dedicated to translating research findings into practical applications that enhance patient care and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported